Design and synthesis of a NAD(P)H:quinone oxidoreductase 1-activatable photosensitiser for controlled photodynamic therapy

被引：8
|
作者：
Xue, Evelyn Y. [1 ]
Kang, Fangyuan [1 ]
Zhou, Yimin [1 ]
Ng, Dennis K. P. [1 ]
机构：
[1] Chinese Univ Hong Kong, Dept Chem, Shatin, Hong Kong, Peoples R China
来源：
CHEMICAL COMMUNICATIONS | 2023年 / 59卷 / 46期
关键词：
STRATEGY; NQO1;
D O I：
10.1039/d3cc00683b
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The utilisation of enzymes as stimuli can activate theranostic agents in a highly specific manner. We report herein a far-red-absorbing boron dipyrromethene-based photosensitiser that is responsive towards the cancer-associated human NAD(P)H:quinone oxidoreductase 1, enabling the controlled restoration of photodynamic activity for selective elimination of cancer cells.
引用
收藏
页码：7056 / 7059
页数：4
相关论文
共 50 条
  • [11] Synthesis and in vitro evaluation of radioiodinated indolequinones targeting NAD(P)H: Quinone oxidoreductase 1 for internal radiation therapy
    Sasaki, Junichi
    Sano, Kohei
    Hagimori, Masayori
    Yoshikawa, Mai
    Maeda, Minoru
    Mukai, Takahiro
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (21) : 6039 - 6046
  • [12] P53-dependent apoptosis and NAD(P)H:quinone oxidoreductase 1
    Asher, G
    Lotem, J
    Sachs, L
    Shaul, Y
    QUINONES AND QUINONE ENZYMES, PT B, 2004, 382 : 278 - 293
  • [13] An electrochemical method to assay the activity of NAD(P)H: Quinone oxidoreductase 1
    Chen, Yangyang
    Liu, Ying
    Chen, Chen
    Lv, Jun
    Zhang, Juan
    Li, Genxi
    SENSORS AND ACTUATORS B-CHEMICAL, 2015, 216 : 343 - 348
  • [14] Overexpression of NAD(P)H:quinone oxidoreductase 1 in human reproductive system
    Zappa, F
    Ward, T
    Butler, J
    Pedrinis, E
    McGown, A
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2001, 49 (09) : 1187 - 1188
  • [15] NAD(P)H:: quinone oxidoreductase 1 expression in multiple sclerosis lesions
    van Horssen, Jack
    Schreibelt, Gerty
    Bo, Lars
    Montagne, Lisette
    Drukarch, Benjamin
    van Muiswinkel, Freek L.
    de Vries, Helga E.
    FREE RADICAL BIOLOGY AND MEDICINE, 2006, 41 (02) : 311 - 317
  • [16] Negative Cooperativity in NAD(P)H Quinone Oxidoreductase 1 (NQO1)
    Megarity, Clare F.
    Benley, Hoda Abdel-Aal
    Caraher, M. Clare
    Scott, Katherine A.
    Whitehead, Roger C.
    Jowitt, Thomas A.
    Gutierrez, Aldo
    Bryce, Richard A.
    Nolan, Karen A.
    Stratford, Ian J.
    Timson, David J.
    CHEMBIOCHEM, 2019, 20 (22) : 2841 - 2849
  • [17] Activation and detoxification of naphthoquinones by NAD(P)H:Quinone oxidoreductase
    Munday, R
    QUINONES AND QUINONE ENZYMES, PT B, 2004, 382 : 364 - 380
  • [18] NAD(P)H: quinone oxidoreductase 1 activatable toll-like receptor 7/8 agonist designed for precise immunotherapy
    Li, Guo
    Xu, Yongxiao
    Kong, Xiaojie
    Gu, Liuwei
    Qin, Yuling
    Wu, Li
    CHEMICAL COMMUNICATIONS, 2023, 59 (42) : 6343 - 6346
  • [19] Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity
    Joseph, P
    Long, DJ
    Klein-Szanto, AJP
    Jaiswal, AK
    BIOCHEMICAL PHARMACOLOGY, 2000, 60 (02) : 207 - 214
  • [20] NAD(P)H: Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 Polymorphisms in Papillary Thyroid Microcarcinoma: Correlation with Phenotype
    Lee, Junguee
    Kim, Koon Soon
    Lee, Min Ho
    Kim, Yeon Soo
    Lee, Min Hee
    Lee, Seong Eun
    Kim, Yong Kyung
    Ryu, Min Jeong
    Kim, Soung Jung
    Choi, Min Jeong
    Jo, Young Suk
    YONSEI MEDICAL JOURNAL, 2013, 54 (05) : 1158 - 1167
12345